Street trees contribute to urban sustainability in South African towns
- Shackleton, Charlie M, Gwedla, Nanamhla
- Authors: Shackleton, Charlie M , Gwedla, Nanamhla
- Date: 2017
- Subjects: City planning -- Environmental aspects Sustainable urban development Community development -- Environmental aspects -- South Africa
- Language: English
- Type: text
- Identifier: http://hdl.handle.net/10962/54269 , vital:26440
- Description: Urban green spaces and trees are increasingly recognised as crucial elements in the quest for urban sustainability internationally, and for the promotion of urban liveability and quality of life in cities. So much so that many countries now have guidelines or regulations regarding either the amount of urban greenery that must be provided per capita, or the maximum distance that any dwelling can be from green spaces of stipulated sizes. For example, the European Union recently more than doubled its recommendation of 9 m2 of public green per person to 20 m2 per person.
- Full Text:
- Date Issued: 2017
- Authors: Shackleton, Charlie M , Gwedla, Nanamhla
- Date: 2017
- Subjects: City planning -- Environmental aspects Sustainable urban development Community development -- Environmental aspects -- South Africa
- Language: English
- Type: text
- Identifier: http://hdl.handle.net/10962/54269 , vital:26440
- Description: Urban green spaces and trees are increasingly recognised as crucial elements in the quest for urban sustainability internationally, and for the promotion of urban liveability and quality of life in cities. So much so that many countries now have guidelines or regulations regarding either the amount of urban greenery that must be provided per capita, or the maximum distance that any dwelling can be from green spaces of stipulated sizes. For example, the European Union recently more than doubled its recommendation of 9 m2 of public green per person to 20 m2 per person.
- Full Text:
- Date Issued: 2017
Spermatophore dimorphism in the chokka squid Loligo reynaudii associated with alternative mating tactics
- Sato, Noriyosi, Iwata, Yoko, Shaw, Paul W, Sauer, Warwick H H
- Authors: Sato, Noriyosi , Iwata, Yoko , Shaw, Paul W , Sauer, Warwick H H
- Date: 2018
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/127070 , vital:35952 , https://doi.10.1093/mollus/eyy002
- Description: Chokka squid (Loligo reynaudii) have characteristic alternative mating tactics: ‘consort’ males temporarily pair with and guard a female and transfer spermatophores onto her oviduct opening inside the mantle cavity, whereas ‘sneaker’ males rush towards a mating pair and transfer spermatophores onto the female’s buccal membrane near her sperm storage organ. Differences in mating behaviours and their related sperm-storage sites clearly constrain the fertilization process and can drive dimorphism between consort and sneaker males. The presence and character of male dimorphism has not yet been fully examined in this species, but consort males are commonly much larger than sneaker males. We observed clear dimorphism in spermatangia (the sperm mass ejaculated from the spermatophore), consistently associated with the two alternative sperm storage sites on the female’s body. Observations of spermatophores stored in the Needham’s sac of mature males confirmed that small males produce ‘sneaker-type’ spermatangia whereas larger males produce ‘consort-type’ spermatangia, and no individuals possessed both types. Therefore, by association, the mating tactic adopted (including the sperm deposition site used) by individual males can be determined from observation of their spermatangial type, without requiring direct behavioural observation of mating. This ability to infer information about mating tactic will improve our understanding of the reproductive system and mating dynamics in this species.
- Full Text:
- Date Issued: 2018
- Authors: Sato, Noriyosi , Iwata, Yoko , Shaw, Paul W , Sauer, Warwick H H
- Date: 2018
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/127070 , vital:35952 , https://doi.10.1093/mollus/eyy002
- Description: Chokka squid (Loligo reynaudii) have characteristic alternative mating tactics: ‘consort’ males temporarily pair with and guard a female and transfer spermatophores onto her oviduct opening inside the mantle cavity, whereas ‘sneaker’ males rush towards a mating pair and transfer spermatophores onto the female’s buccal membrane near her sperm storage organ. Differences in mating behaviours and their related sperm-storage sites clearly constrain the fertilization process and can drive dimorphism between consort and sneaker males. The presence and character of male dimorphism has not yet been fully examined in this species, but consort males are commonly much larger than sneaker males. We observed clear dimorphism in spermatangia (the sperm mass ejaculated from the spermatophore), consistently associated with the two alternative sperm storage sites on the female’s body. Observations of spermatophores stored in the Needham’s sac of mature males confirmed that small males produce ‘sneaker-type’ spermatangia whereas larger males produce ‘consort-type’ spermatangia, and no individuals possessed both types. Therefore, by association, the mating tactic adopted (including the sperm deposition site used) by individual males can be determined from observation of their spermatangial type, without requiring direct behavioural observation of mating. This ability to infer information about mating tactic will improve our understanding of the reproductive system and mating dynamics in this species.
- Full Text:
- Date Issued: 2018
Ferrocenyl and organic novobiocin derivatives: synthesis and their in vitro biological activity
- Mbaba, Mziyanda, Mabhula, Amanda N, Boel, Natasha, Edkins, Adrienne L, Isaacs, Michelle, Hoppe, Heinrich C, Khanye, Setshaba D
- Authors: Mbaba, Mziyanda , Mabhula, Amanda N , Boel, Natasha , Edkins, Adrienne L , Isaacs, Michelle , Hoppe, Heinrich C , Khanye, Setshaba D
- Date: 2017
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/66189 , vital:28914 , https://doi.org/10.1016/j.jinorgbio.2017.04.014
- Description: publisher version , A focused series of novobiocin derivatives containing a ferrocene unit together with their corresponding organic novobiocin analogues have been synthesized in modest to good yields. These compounds were screened for biological activity against a chloroquine-sensitive strain of Plasmodium falciparum (3D7) and human breast cancer cell line (HCC38). With the exception of compounds 5c and 5d, the general trend observed is that incorporation of the ferrocene moiety into novobiocin scaffold resulted in compounds 6a–d/6f showing enhanced activity compared to organic analogues 5a–b and 5e–f.
- Full Text: false
- Date Issued: 2017
- Authors: Mbaba, Mziyanda , Mabhula, Amanda N , Boel, Natasha , Edkins, Adrienne L , Isaacs, Michelle , Hoppe, Heinrich C , Khanye, Setshaba D
- Date: 2017
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/66189 , vital:28914 , https://doi.org/10.1016/j.jinorgbio.2017.04.014
- Description: publisher version , A focused series of novobiocin derivatives containing a ferrocene unit together with their corresponding organic novobiocin analogues have been synthesized in modest to good yields. These compounds were screened for biological activity against a chloroquine-sensitive strain of Plasmodium falciparum (3D7) and human breast cancer cell line (HCC38). With the exception of compounds 5c and 5d, the general trend observed is that incorporation of the ferrocene moiety into novobiocin scaffold resulted in compounds 6a–d/6f showing enhanced activity compared to organic analogues 5a–b and 5e–f.
- Full Text: false
- Date Issued: 2017
Isolation, identification and genetic characterisation of a microsporidium isolated from carob moth, Ectomyelois ceratoniae (Zeller) (Lepidoptera: Pyralidae)
- Lloyd, Melissa, Knox, Caroline M, Hill, Martin P, Moore, Sean D
- Authors: Lloyd, Melissa , Knox, Caroline M , Hill, Martin P , Moore, Sean D
- Date: 2017
- Language: English
- Type: article , text
- Identifier: http://hdl.handle.net/10962/59874 , vital:27674 , https://doi.org/10.4001/003.025.0529
- Description: 'Microsporidia' is a term used for organisms belonging to the phylum Microspora, which contains approximately 187 genera and 1500 species (Corradi 2015). They are obligate intracellular parasites with no active metabolic stages of the life cycle occurring outside of the host cells (Franzen & Muller 1999; Garcia 2002; Tsai et al. 2003; Huang et al. 2004). They exhibit eukaryotic characteristics such as a membrane-bound nucleus, an intracytoplasmic membrane system, and chromosome separation occurs on mitotic spindles. However, they also exhibit prokaryotic characteristics such as possession of a 70S ribosome, lack of true mitochondria and peroxisomes, a simple version of the Golgi apparatus, and a small genome which is much less complex than those of most eukaryotes (Franzen & Muller 1999; Garcia 2002). Microspo- ridia are parasitic in all major groups of animals, both vertebrates and invertebrates (Sprague 1977; Franzen & Muller 1999). Microsporidia were first recognised as pathogens in silkworms by Nageli (1857), and now have been found to infect many hosts such as humans, insects, fish and mammals (Stentiford et al. 2016).
- Full Text:
- Date Issued: 2017
- Authors: Lloyd, Melissa , Knox, Caroline M , Hill, Martin P , Moore, Sean D
- Date: 2017
- Language: English
- Type: article , text
- Identifier: http://hdl.handle.net/10962/59874 , vital:27674 , https://doi.org/10.4001/003.025.0529
- Description: 'Microsporidia' is a term used for organisms belonging to the phylum Microspora, which contains approximately 187 genera and 1500 species (Corradi 2015). They are obligate intracellular parasites with no active metabolic stages of the life cycle occurring outside of the host cells (Franzen & Muller 1999; Garcia 2002; Tsai et al. 2003; Huang et al. 2004). They exhibit eukaryotic characteristics such as a membrane-bound nucleus, an intracytoplasmic membrane system, and chromosome separation occurs on mitotic spindles. However, they also exhibit prokaryotic characteristics such as possession of a 70S ribosome, lack of true mitochondria and peroxisomes, a simple version of the Golgi apparatus, and a small genome which is much less complex than those of most eukaryotes (Franzen & Muller 1999; Garcia 2002). Microspo- ridia are parasitic in all major groups of animals, both vertebrates and invertebrates (Sprague 1977; Franzen & Muller 1999). Microsporidia were first recognised as pathogens in silkworms by Nageli (1857), and now have been found to infect many hosts such as humans, insects, fish and mammals (Stentiford et al. 2016).
- Full Text:
- Date Issued: 2017
Roundtable review: cold case: the elusive story of Julie Ward's murder
- Authors: Spencer, Lynda G
- Date: 2017
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/138894 , vital:37683 , https://doi.org/10.1080/23277408.2017.1362199
- Description: A Death Retold in Truth and Rumour: Kenya, Britain and the Julie Ward Murder by Grace Ahingila Musila is an extraordinary, captivating, thought-provoking and chilling account of the unsolved murder of Julie Ward. Musila points out that this book does not set out to reveal who murdered Julie Ward. Instead, as an academic, she is interested in examining the intertextual process between the rumours around this cold case and the evidence available in various published accounts, such as books, newspapers and court judgements.
- Full Text:
- Date Issued: 2017
- Authors: Spencer, Lynda G
- Date: 2017
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/138894 , vital:37683 , https://doi.org/10.1080/23277408.2017.1362199
- Description: A Death Retold in Truth and Rumour: Kenya, Britain and the Julie Ward Murder by Grace Ahingila Musila is an extraordinary, captivating, thought-provoking and chilling account of the unsolved murder of Julie Ward. Musila points out that this book does not set out to reveal who murdered Julie Ward. Instead, as an academic, she is interested in examining the intertextual process between the rumours around this cold case and the evidence available in various published accounts, such as books, newspapers and court judgements.
- Full Text:
- Date Issued: 2017
Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy
- Hofmeyr, Georges Justus, Manyame, S
- Authors: Hofmeyr, Georges Justus , Manyame, S
- Date: 2017
- Subjects: South Africa Pregnancy Computer File
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/11260/6215 , vital:45282 , "https://DOI:10.1002/14651858.CD011192.pub2"
- Description: Background Pre-eclampsia is considerably more prevalent in low- than high-income countries. One possible explanation for this discrepancy is dietary diKerences, particularly calcium deficiency. Calcium supplementation in the second half of pregnancy reduces the serious consequences of pre-eclampsia and is recommended by the WorldHealthOrganization (WHO) for women with low dietary calcium intake, but has limited eKect on the overallrisk of pre-eclampsia. It is important to establish whether calcium supplementation before and in early pregnancy has added benefit. Such evidence would be justification for population-level fortification of staple foods with calcium. Objectives To determine the eKect of calcium supplementation or food fortification with calcium, commenced before or early in pregnancy and continued at least until mid-pregnancy, on pre-eclampsia and other hypertensive disorders, maternal morbidity and mortality, as well as fetal and neonatal outcomes. Search methods We searched the Cochrane Pregnancy and Childbirth Trials Register (10 August 2017), PubMed (29 June 2017), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (10 August 2017) and reference lists of retrieved studies. Selection criteria Randomised controlled trials of calcium supplementation orfood fortification which include women of child bearing age not yet pregnant, or in early pregnancy. Cluster-RCTs, quasi-RCTs and trials published in abstract form only would have been eligible for inclusion in this review but none were identified. Cross-over designs are not appropriate for this intervention. The scope of this review is to consider interventions including calcium supplementation with or without additional supplements or treatments, compared with placebo or no intervention. Data collection and analysis Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. Main results This review is based on one RCT (involving 60 women) which looked at calcium plus additional supplements versus control. The women (who had lowantioxidant status)were in the early stages of pregnancy.We did notidentify any studieswhere supplementation commenced pre-pregnancy. Another RCT comparing calcium versus placebo is ongoing but not yet complete. We did not identify any studies looking at any of our other planned comparisons. Calcium plus antioxidants and other supplements versus placebo We included one small study (involving 60 women with low antioxidantlevels) which was conducted in an academic hospital in Indondesia. The study was at low risk of bias for all domains with the exception of selective reporting, for which it was unclear. Women in the intervention group received calcium (800 mg) plus N-acetylcysteine (200 mg), Cu (2 mg), Zn (15 mg), Mn (0.5 mg) and selenium (100 mcg) and vitamins A (1000 IU), B6 (2.2 mg), B12 (2.2 mcg), C (200 mg), and E (400 IU) versus the placebo control group of women who received similar looking tablets containing iron and folic acid. Both groups received iron (30 mg) and folic acid (400 mcg). Tablets were taken twice daily from eight to 12 weeks of gestation and then throughout pregnancy. The included study found that calcium supplementation plus antioxidants and other supplements may slightly reduce pre-eclampsia (gestational hypertension and proteinuria) (risk ratio (RR) 0.24, 95% confidence interval (CI) 0.06 to 1.01; low-quality evidence), but this is uncertain due to wide confidence intervals just crossing the line of no eKect, and small sample size. It appears that earlypregnancy loss before 20 weeks' gestation (RR 0.06, 95% CI 0.00 to 1.04; moderate-quality evidence) may be slightly reduced by calcium plus antioxidants and other supplements, but this outcome also has wide confidence intervals, which just cross the line of no eKect. Very few events were reported under the composite outcome, severe maternal morbidity and mortality index and no clear diKerence was seen between groups (RR 0.36, 95% CI 0.04 to 3.23; low-quality evidence). However, the included study observed a reduction in the composite outcome pre-eclampsia and/or pregnancy loss at any gestational age (RR 0.13, 95% CI 0.03 to 0.50; moderate-quality evidence), and pregnancy loss/stillbirth at any gestational age (RR 0.06, 95% CI 0.00 to 0.92;moderate-quality evidence)in the calcium plus antioxidant/supplement group. Other outcomes reported (placental abruption, severe pre-eclampsia and preterm birth (less than 37 weeks' gestation)) were too infrequent for meaningful analysis. No data were reported for the outcomes caesarean section, birthweight less 2500 g, Apgar score less than seven at five minutes, death or admission to neonatal intensive care unit (ICU), or pregnancy loss, stillbirth or neonatal death before discharge from hospital. Authors' conclusions The results of this review are based on one small study in which the calcium intervention group also received antioxidants and other supplements. Therefore, we are uncertain whether any of the eKects observed in the study were due to calcium supplementation or not. The evidence in this review was graded low to moderate due to imprecision. There is insuKicient evidence on the eKectiveness or otherwise of pre- or early-pregnancy calcium supplementation, or food fortification for preventing hypertensive disorders of pregnancy. Furtherresearch is needed to determine whether pre- or early-pregnancy supplementation, orfood fortification with calcium is associated with a reduction in adverse pregnancy outcomes such as pre-eclampsia and pregnancy loss. Such studies should be adequately powered, limited to calcium supplementation, placebo-controlled, and include relevant outcomes such as those chosen for this review. There is one ongoing study of calcium supplementation alone versus placebo and this may provide additional evidence in future updates
- Full Text:
- Date Issued: 2017
- Authors: Hofmeyr, Georges Justus , Manyame, S
- Date: 2017
- Subjects: South Africa Pregnancy Computer File
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/11260/6215 , vital:45282 , "https://DOI:10.1002/14651858.CD011192.pub2"
- Description: Background Pre-eclampsia is considerably more prevalent in low- than high-income countries. One possible explanation for this discrepancy is dietary diKerences, particularly calcium deficiency. Calcium supplementation in the second half of pregnancy reduces the serious consequences of pre-eclampsia and is recommended by the WorldHealthOrganization (WHO) for women with low dietary calcium intake, but has limited eKect on the overallrisk of pre-eclampsia. It is important to establish whether calcium supplementation before and in early pregnancy has added benefit. Such evidence would be justification for population-level fortification of staple foods with calcium. Objectives To determine the eKect of calcium supplementation or food fortification with calcium, commenced before or early in pregnancy and continued at least until mid-pregnancy, on pre-eclampsia and other hypertensive disorders, maternal morbidity and mortality, as well as fetal and neonatal outcomes. Search methods We searched the Cochrane Pregnancy and Childbirth Trials Register (10 August 2017), PubMed (29 June 2017), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (10 August 2017) and reference lists of retrieved studies. Selection criteria Randomised controlled trials of calcium supplementation orfood fortification which include women of child bearing age not yet pregnant, or in early pregnancy. Cluster-RCTs, quasi-RCTs and trials published in abstract form only would have been eligible for inclusion in this review but none were identified. Cross-over designs are not appropriate for this intervention. The scope of this review is to consider interventions including calcium supplementation with or without additional supplements or treatments, compared with placebo or no intervention. Data collection and analysis Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. Main results This review is based on one RCT (involving 60 women) which looked at calcium plus additional supplements versus control. The women (who had lowantioxidant status)were in the early stages of pregnancy.We did notidentify any studieswhere supplementation commenced pre-pregnancy. Another RCT comparing calcium versus placebo is ongoing but not yet complete. We did not identify any studies looking at any of our other planned comparisons. Calcium plus antioxidants and other supplements versus placebo We included one small study (involving 60 women with low antioxidantlevels) which was conducted in an academic hospital in Indondesia. The study was at low risk of bias for all domains with the exception of selective reporting, for which it was unclear. Women in the intervention group received calcium (800 mg) plus N-acetylcysteine (200 mg), Cu (2 mg), Zn (15 mg), Mn (0.5 mg) and selenium (100 mcg) and vitamins A (1000 IU), B6 (2.2 mg), B12 (2.2 mcg), C (200 mg), and E (400 IU) versus the placebo control group of women who received similar looking tablets containing iron and folic acid. Both groups received iron (30 mg) and folic acid (400 mcg). Tablets were taken twice daily from eight to 12 weeks of gestation and then throughout pregnancy. The included study found that calcium supplementation plus antioxidants and other supplements may slightly reduce pre-eclampsia (gestational hypertension and proteinuria) (risk ratio (RR) 0.24, 95% confidence interval (CI) 0.06 to 1.01; low-quality evidence), but this is uncertain due to wide confidence intervals just crossing the line of no eKect, and small sample size. It appears that earlypregnancy loss before 20 weeks' gestation (RR 0.06, 95% CI 0.00 to 1.04; moderate-quality evidence) may be slightly reduced by calcium plus antioxidants and other supplements, but this outcome also has wide confidence intervals, which just cross the line of no eKect. Very few events were reported under the composite outcome, severe maternal morbidity and mortality index and no clear diKerence was seen between groups (RR 0.36, 95% CI 0.04 to 3.23; low-quality evidence). However, the included study observed a reduction in the composite outcome pre-eclampsia and/or pregnancy loss at any gestational age (RR 0.13, 95% CI 0.03 to 0.50; moderate-quality evidence), and pregnancy loss/stillbirth at any gestational age (RR 0.06, 95% CI 0.00 to 0.92;moderate-quality evidence)in the calcium plus antioxidant/supplement group. Other outcomes reported (placental abruption, severe pre-eclampsia and preterm birth (less than 37 weeks' gestation)) were too infrequent for meaningful analysis. No data were reported for the outcomes caesarean section, birthweight less 2500 g, Apgar score less than seven at five minutes, death or admission to neonatal intensive care unit (ICU), or pregnancy loss, stillbirth or neonatal death before discharge from hospital. Authors' conclusions The results of this review are based on one small study in which the calcium intervention group also received antioxidants and other supplements. Therefore, we are uncertain whether any of the eKects observed in the study were due to calcium supplementation or not. The evidence in this review was graded low to moderate due to imprecision. There is insuKicient evidence on the eKectiveness or otherwise of pre- or early-pregnancy calcium supplementation, or food fortification for preventing hypertensive disorders of pregnancy. Furtherresearch is needed to determine whether pre- or early-pregnancy supplementation, orfood fortification with calcium is associated with a reduction in adverse pregnancy outcomes such as pre-eclampsia and pregnancy loss. Such studies should be adequately powered, limited to calcium supplementation, placebo-controlled, and include relevant outcomes such as those chosen for this review. There is one ongoing study of calcium supplementation alone versus placebo and this may provide additional evidence in future updates
- Full Text:
- Date Issued: 2017
- «
- ‹
- 1
- ›
- »